Cautiously Optimistic Outlook for Cigna: Buy Rating Backed by Conservative Guidance and Growth Potential
Jefferies analyst David Windley has maintained their bullish stance on CI stock, giving a Buy rating today.Invest with Confidence: Follow ...
Optimistic Outlook for Vertex Pharmaceuticals: Strong Performance, New Approvals, and Promising Pipeline Drive Buy Rating
Analyst Michael Yee of Jefferies maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report), retaining the price target of ...